Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184971 · ClinicalTrials.gov registry record
Biliary Atresia Research Network Northeast
A clinical trial of Biliary Atresia, sponsored by Yale University.
- Recruiting
- Registry status
- 150
- Enrollment target
- 14
- Study locations
NCT06184971: Recruiting study of Biliary Atresia, sponsored by Yale University.
NCT06184971 is a study of Biliary Atresia that is actively recruiting participants, run by Yale University. The registered enrollment target is 150 participants, below the 554-participant average among 7 other Biliary Atresia trials with a reported enrollment target (73% lower). The trial reports 14 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06184971, a study of Biliary Atresia, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 14
- Study locations
Study Summary
This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investigators aim to evaluate which specific factors contribute to improved patient outcomes, to help guide potential improvements in patient care and resource utilization.
Primary Outcome
Patient death
Conditions Studied
Study Locations (14)
Massachusetts
- Massachusetts General Hospital for Children - Boston
- Boston Children's Hospital - Boston
- Baystate - Springfield
- UMass Memorial Medical Center - Worcester
New York
- Albany Medical Center/Bernard & Millie Duke's Children's Hospital - Albany
- John R. Oishei Children's Hospital - Buffalo
- University of Rochester Medical Center/Golisano Children's Hospital - Rochester
- SUNY Upstate Medical University - Syracuse
Connecticut
- Connecticut Children's Medical Center - Hartford
- Yale University - New Haven
Maine
- Eastern Maine Medical Center - Bangor
- Maine Medical Center - Portland
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Rhode Island
- Rhode Island Hospital/Hasbro Children's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-05-06 |
| Est. Completion | 2025-12 |
What NCT06184971 shows while recruiting
NCT06184971 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 554-participant average among 7 other Biliary Atresia trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Biliary Atresia appearing as the primary indexed condition, and to 0 interventions.
NCT06184971 lists 14 locations in 6 states (Massachusetts, New York, Connecticut).
Frequently Asked Questions
What is clinical trial NCT06184971 about?
NCT06184971 is a clinical study titled "Biliary Atresia Research Network Northeast". This is a multi-center retrospective chart review to compile a data repository of the management and outcomes of children with biliary atresia. Overall, investigators aim to evaluate which specific factors contribute to improved patient outcomes, to help guide potential improvements in patient care ...
What is the current status of trial NCT06184971?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-05-06. Estimated completion is 2025-12.
What conditions does trial NCT06184971 study?
This clinical trial studies the following conditions: Biliary Atresia.
Who is sponsoring clinical trial NCT06184971?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06184971 being conducted?
This trial has 14 study locations across Connecticut, Maine, Massachusetts, New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Atresia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Disease Pathways for Biliary Atresia
RECRUITING
-
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
RECRUITING · Phase 1
-
A Prospective Database of Infants With Cholestasis
RECRUITING
-
Biliary Atresia Study in Infants and Children
RECRUITING
-
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
RECRUITING · Early Phase 1
-
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI